PEAK6 Investments’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-14,500
Closed -$263K 6068
2021
Q3
$263K Sell
14,500
-18,200
-56% -$417K ﹤0.01% 3784
2021
Q2
$883K Sell
32,700
-20,200
-38% -$565K ﹤0.01% 2702
2021
Q1
$1.58M Sell
52,900
-38,900
-42% -$1.33M ﹤0.01% 2116
2020
Q4
$2.64M Sell
91,800
-85,600
-48% -$2.31M 0.01% 1617
2020
Q3
$4.33M Buy
177,400
+129,100
+267% +$2.78M 0.01% 1056
2020
Q2
$864K Buy
+48,300
New +$635K ﹤0.01% 2223

Other funds holding CVET

PEAK6 Investments's CVET Position: Q4 2021 in Review

PEAK6 Investments sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2021, closing a stake of 12,227 shares — an estimated $222K sold.

PEAK6 Investments first reported a position in CVET in Q2 2021 and held it in 2 quarters. The position peaked at $222K in Q3 2021. 246 funds tracked by Wall St. Rank hold CVET as of Q4 2021.

  • PEAK6 Investments reported no remaining Covetrus, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • PEAK6 Investments sold 12,227 Covetrus, Inc. Common Stock shares in Q4 2021, an estimated $222K.
  • PEAK6 Investments first reported a position in Covetrus, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • PEAK6 Investments's Covetrus, Inc. Common Stock position peaked at $222K in Q3 2021.
  • 246 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2021.

Based on PEAK6 Investments's 13F filing for Q4 2021, filed 11 Feb 2022.